Talent or Greediness?

Talent or Greediness? The letter entitled "The Misery,"1 signed by a retired lawyer, has called forth conflicting emotions and thoughts, and a certain amount of dissatisfaction and discomfort in the undersigned, both devoted scientists. Although it is undeniably true that the author did succeed in bringing out some interesting arguments, in our opinion, and with all due respect, we reckon that he entirely missed the point. We won't discuss here his surely arguable statement that "getting ri

Written byCarlos Garbisu
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The letter entitled "The Misery,"1 signed by a retired lawyer, has called forth conflicting emotions and thoughts, and a certain amount of dissatisfaction and discomfort in the undersigned, both devoted scientists. Although it is undeniably true that the author did succeed in bringing out some interesting arguments, in our opinion, and with all due respect, we reckon that he entirely missed the point. We won't discuss here his surely arguable statement that "getting rich takes a talent," but the fact is that most good scientists simply do not care about getting rich. In other words, "getting rich" is clearly not at the top of most good scientists' priority list.

Becoming and being a real scientist demands a strong and robust vocation, essential to confront the inevitable intense dedication required to deal with the many challenges and difficulties encountered in our daily scientific tasks. Good scientists are driven by an incurable, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies